Clarence R. Manuel

Clarence R. Manuel is a senior scientist at Pfizer's Viral Vaccines department. Clarence has dedicated their career to researching and developing treatments for heart disease and diabetes. Clarence has worked at the American Heart Association, Einstein-Mount Sinai Diabetes Center, and NYIT's Weill Cornell Medicine, among other institutions. In 2018, they were awarded the American Society for Cell Biology/EMBO Annual Meeting's prestigious "Outstanding Abstract" award.

Clarence R. Manuel has a Doctor of Philosophy (PhD) in Pharmacology from St. John's University, a Masters of Biomedical Science in Pharmacological Sciences from Rutgers New Jersey Medical School, and a Bachelor of Arts (B.A.) in English Language and Literature, General from College of Saint Benedict and Saint John's University. Clarence also has a High School Diploma from St. Benedict's Prep School and a certification from The New York Academy of Sciences in 2016 Science Alliance Leadership Training (SALT).